BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 1087211)

  • 1. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.
    Shirai T; Miyata M; Nakase A; Itoh T
    Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.
    Piantelli M; Musiani P; Lauriola L; Carbone A; Tonali P; Dina MA
    Clin Exp Immunol; 1980 Jul; 41(1):19-24. PubMed ID: 6969152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis: mitotic activity of thymus-dependent and blood-lymphocytes.
    Szobor A; Staub M; Szathmáry I; Csuka I; Antoni F
    Acta Med Acad Sci Hung; 1976; 33(1):25-39. PubMed ID: 1088241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic lymphocytes in myasthenia gravis.
    Birnbaum G; Tsairis P
    Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subpopulations of lymphocytes in human thymomas.
    Lauriola L; Piantelli M; Carbone A; Dina MA; Scoppetta C; Musiani P
    Clin Exp Immunol; 1979 Sep; 37(3):502-6. PubMed ID: 315846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis.
    Aarli JA; Heimann P; Matre R; Thunold S; Tönder O
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thymus in myasthenia gravis. Evidence for altered cell populations.
    Abdou NI; Lisak RP; Zweiman B; Abrahamsohn I; Penn AS
    N Engl J Med; 1974 Dec; 291(24):1271-5. PubMed ID: 4279335
    [No Abstract]   [Full Text] [Related]  

  • 11. Perivascular infiltrate of memory lymphocytes and mature dendritic cells in MG thymomas.
    Nagane Y; Utsugisawa K; Akutsu H; Sato Y; Terayama Y
    Neurology; 2005 Sep; 65(5):770-2. PubMed ID: 16157920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological effects of thymectomy in myasthenia gravis.
    Scadding GK; Thomas HC; Havard CW
    Clin Exp Immunol; 1979 May; 36(2):205-13. PubMed ID: 314366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in clinical and immunological status after post-thymectomized irradiation for invasive thymoma with myasthenia gravis].
    Ishida S
    Rinsho Shinkeigaku; 1996 May; 36(5):629-32. PubMed ID: 8905980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
    Fujii Y; Hayakawa M; Inada K; Nakahara K
    Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
    Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
    J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
    Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A
    Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double labelled T suppressor lymphocytes in the thymus of a patient with myasthenia gravis: morphological and immunological characteristics.
    Bárdosi L; Ambrus M; Koltay M; Karlinger GT; Gellért M
    J Clin Lab Immunol; 1982 Jan; 7(1):75-80. PubMed ID: 6461769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.